Related Experiment Video
Updated: Nov 1, 2025
An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
Paulo Eduardo Ocke Reis1, Marcos Cesar Braga Lima1
1Universidade Federal Fluminense - UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil.
Insights
Adding COVID-19 to the CHA2DS2-VASc score can identify patients at high risk for dangerous blood clots. This modification helps guide early preventative treatment to reduce severe illness and mortality in COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 is frequently associated with thromboembolic complications, significantly worsening patient outcomes.
- Thromboembolic events in COVID-19 patients can lead to severe disease progression, intensive care unit (ICU) admission, and increased mortality.
Purpose of the Study:
- To propose a modified CHA2DS2-VASc score that incorporates COVID-19 status to improve risk stratification for thromboembolic events.
- To facilitate early initiation of prophylactic anticoagulation in at-risk COVID-19 patients.
Main Methods:
- The study proposes a modification to the existing CHA2DS2-VASc score by adding one point for patients diagnosed with COVID-19.
- This modified score aims to identify individuals requiring thromboembolic prophylaxis.
Main Results:
- The proposed modification aims to enhance the predictive accuracy of the CHA2DS2-VASc score for thromboembolic risk in the context of COVID-19.
- Early prophylaxis guided by the modified score is expected to prevent disease worsening and reduce the need for mechanical ventilation.
Conclusions:
- A modified CHA2DS2-VASc score, including a point for COVID-19, can aid in the early identification and management of thromboembolic risk.
- Implementing this score modification may prevent severe COVID-19 complications, decrease ICU admissions, and ultimately reduce mortality.
Abstract:
Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA2DS2-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient's condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.
More Related Videos
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:21Rheumatic Heart Disease III: Medical Management